World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
26796
World Ranking
16538
National Ranking
8309

Overview

Andrew M. Lowy is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant emphasis on oncology and cancer-related studies.

Their body of work includes numerous publications that extensively cover topics such as pancreatic and hepatic oncology research, cancer genomics and diagnostics, intraperitoneal and appendiceal malignancies, cancer cells and metastasis, privacy-preserving technologies in data, epigenetics and DNA methylation, and appendicitis diagnosis and management.

Frequent publication venues for their work include:

  • Cancer Research
  • arXiv (Cornell University)
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Gastroenterology

Common co-authors who have contributed to their research projects are:

  • Hervé Tiriac
  • Evangeline Mose
  • Joel Baumgartner
  • Jula Veerapong
  • Kaitlyn J. Kelly

Notable recent papers include:

  • Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology (2021), published in Journal of the National Comprehensive Cancer Network
  • Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma (2021), published in JAMA Oncology
  • Surgical Outcome Results From SWOG S1505 (2020), published in Annals of Surgery
  • Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome (2022), published in Nature
  • Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis (2021), published in Cancer Cell

Their work spans several oncology subfields, including Oncology, Surgery, Molecular Biology, Cancer Research, and Immunology.

Best Publications

  • Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

    Sunil R. Hingorani;Emanuel F. Petricoin;Anirban Maitra;Vinodh Rajapakse

  • Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Horacio Asbun

  • Pancreatic adenocarcinoma, Version 2.2021

    Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Stephen W. Behrman

  • Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

    Jennifer P. Morton;Paul Timpson;Saadia A. Karim;Rachel A. Ridgway

  • Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

    F. R. Spitz;J. L. Abbruzzese;Jeffrey E Lee;Peter W Pisters

  • Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.

    Matthew H.G. Katz;Qian Shi;Syed A. Ahmad;Joseph M. Herman

  • Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.

    Andrew Lowy;Jeffrey Lee;Peter Pisters;B. Davidson

  • Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches.

    David A. Kooby;David A. Kooby;Theresa Gillespie;Theresa Gillespie;David Jason Bentrem;Attila Nakeeb

  • beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.

    Wilson M Clements;Jiang Wang;Amod Sarnaik;On Ja Kim

  • Pancreatic Adenocarcinoma, Version 2.2014

    Margaret A. Tempero;Mokenge P. Malafa;Stephen W. Behrman;Al B. Benson

  • SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

    Edgar Ben-Josef;Katherine A. Guthrie;Anthony B. El-Khoueiry;Christopher L. Corless

  • An integrin β 3 –KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition

    Laetitia Seguin;Shumei Kato;Aleksandra Franovic;M. Fernanda Camargo

  • Survival following pancreaticoduodenectomy with resection of the superior mesenteric–portal vein confluence for adenocarcinoma of the pancreatic head

    S. D. Leach;J. E. Lee;C. Charnsangavej;K. R. Cleary

  • Surgery for Pancreatic Cancer: Recent Controversies and Current Practice

    Curtis J. Wray;Syed A. Ahmad;Jeffrey B. Matthews;Andrew M. Lowy

  • Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

    Yu Shi;Weina Gao;Nikki K. Lytle;Peiwu Huang;Peiwu Huang

  • Therapeutic advances in pancreatic cancer.

    Andrew Scott Paulson;Hop S. Tran Cao;Margaret A. Tempero;Andrew M. Lowy

  • Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.

    Andrew M. Lowy;Paul F. Mansfield;Steven D. Leach;Richard Pazdur

  • Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

    Matthew Harold Katz;Robert Marsh;Joseph M. Herman;Qian Shi

  • Sox17 Regulates Organ Lineage Segregation of Ventral Foregut Progenitor Cells

    Jason R. Spence;Alex W. Lange;Suh Chin J. Lin;Klaus H. Kaestner

  • Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

    Ross A. Abrams;Andrew M. Lowy;Eileen M. O’Reilly;Robert A. Wolff

Frequent Co-Authors

Philip A. Philip
Philip A. Philip Wayne State University
Michael Bouvet
Michael Bouvet University of California, San Diego
Tambet Teesalu
Tambet Teesalu University of Tartu
Paul A. Insel
Paul A. Insel University of California, San Diego
Howard S. Hochster
Howard S. Hochster Yale University
Hedy L. Kindler
Hedy L. Kindler University of Chicago
Paul F. Mansfield
Paul F. Mansfield The University of Texas MD Anderson Cancer Center
Erkki Ruoslahti
Erkki Ruoslahti Sanford Burnham Prebys Medical Discovery Institute
David A. Cheresh
David A. Cheresh University of California, San Diego
Edward A. Levine
Edward A. Levine Wake Forest University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary career pathways to medicine can open doors to a variety of roles in healthcare. Online degrees make these options more accessible, letting students upskill or change fields while maintaining flexibility.

For those interested in mental health and advanced nursing roles, online psych np programs are a fast-growing field. These programs can lead to careers as psychiatric nurse practitioners, providing critical care in mental health settings.

If you’re drawn to the business and leadership side of healthcare, a bachelors in healthcare administration can be a smart starting point. Building on that, an affordable mha online enables graduates to qualify for advanced management or executive roles in medical institutions.

For nurses aiming for the top of their profession, a 1 year dnp program online offers a quick path to leadership, education, or specialized clinical roles.

These online degrees can help you chart your own unique career path in the dynamic healthcare industry.

Best Scientists Citing Andrew M. Lowy

Trending Scientists

Recently Published Articles